Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-16 Purchase |
2022-03-18 8:01 pm |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
3,000 | $3.98 | $11,940 | 55,000 (Direct) |
View |
| 2021-11-17 Purchase |
2021-11-18 9:12 pm |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
2,000 | $7 | $14,000 | 2,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-01 Option Award |
2022-03-01 7:29 pm |
N/A 2032-02-29 |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
122,568 | $0 | 124,568 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-05 4:53 pm |
N/A 2031-02-03 |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
137,000 | $0 | 137,000 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A 2029-10-16 |
Poseida Therapeutics Inc. | PSTX | Ingalls Kerry D. Chief Operating Officer |
0 | $0 | 128,307 (Direct) |
View |